Regulacje i polityka gospodarcza · 14/09/2004
NIH Seeks Licensee(s) for Live Attenuated RSV, HMPV, and PIV Vaccines
The National Institutes of Health (NIH) is looking for a partner to develop, test, and market live attenuated virus vaccines for RSV, HMPV, and PIV, building on NIH's research in the Laboratory of Infectious Diseases.